Acadia Pharmaceuticals Sees FY24 Total Revenue $930M-$980M vs $953.15M Est.
Portfolio Pulse from Benzinga Newsdesk
Acadia Pharmaceuticals has projected its FY24 total revenue to be in the range of $930 million to $980 million, compared to the estimated $953.15 million.
August 06, 2024 | 9:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Acadia Pharmaceuticals has projected its FY24 total revenue to be in the range of $930 million to $980 million, compared to the estimated $953.15 million.
The revenue projection is slightly above the market estimate, which is likely to have a positive short-term impact on the stock price as it indicates potential growth and better-than-expected performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100